OTC · Biotechnology

Actavia Life Sciences, Inc. (RASP) Stock

$0.00 OTC: RASP Healthcare

Actavia Life Sciences, Inc. operates as a biotechnology enterprise specializing in the development of therapeutic solutions aimed at treating various forms of leukemia and lymphoma.

Valuation

MetricValue
Price$0.00
Market Cap$385906
P/E Ratio-0.06
P/B Ratio-0.15
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE200.00%
ROA—
ROCE216.68%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio0.05

Annual Financials (USD)

Metric20192020202120222023
Revenue$0$0$0$0$0
Operating Profit$-1.0M$-5.0M$0$0$-4.0M
Net Profit$-1.0M$-5.0M$-1.0M$-1.0M$-4.0M
EPS$-0.01$-0.08$-0.01$-0.01$-0.01
Op Margin—————

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$5.0M$0$0$0$0
Total Liabilities$2.0M$3.0M$3.0M$2.0M$2.0M
Cash$0$0$0$0$0
Borrowings$0$1.0M$1.0M$0$0

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$0$0$0$0$0
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$0$0$0$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-1.37
FCF Yield-2.21%
Quick Ratio0.06
Interest Coverage-19.90
Return 1Y-87.50%
Return 3Y-97.78%
Return 5Y—

Ownership

Insiders Held85.19%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CHNXFChitogenX Inc. $0.01 +0.00% -0.23 $627628 0.00%
IPIXInnovation Pharmaceuticals Inc. $0.00 — -0.32 $1.04M 0.00%
LFCOFLift & Co. Corp. $0.00 — -0.01 $63446 0.00%
MDINMedGen, Inc. $0.00 — -600.00 $90309 0.00%
NBIONascent Biotech, Inc. $0.00 — -0.04 $103330 0.00%

About Actavia Life Sciences, Inc.

Actavia Life Sciences, Inc. operates as a biotechnology enterprise specializing in the development of therapeutic solutions aimed at treating various forms of leukemia and lymphoma. Additionally, the company is engaged in formulating small molecule drug candidates, with a particular emphasis on addressing acute myeloid leukemia. Established in 2013, its corporate headquarters are situated in New York, NY.

Actavia Life Sciences, Inc. (RASP) stock trades at $0.00 with a market capitalization of $385906. The stock is valued at a price-to-earnings (P/E) ratio of -0.06, price-to-book of -0.15, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Actavia Life Sciences, Inc. generates a return on equity (ROE) of 200.00% — well above the market average, a sign of a high-quality business, return on capital employed of 216.68%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.rasna.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides